Document Detail


Medical and surgical treatment of ectopic pregnancy.
MedLine Citation:
PMID:  8193254     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Laparoscopic removal of the products of conception remains the treatment of choice for ectopic pregnancy (EP). Systemic administration of methotrexate (MTX) is a promising new treatment; however, its efficacy has to be established in clinical trials. Local treatment by laparoscopy with MTX, prostaglandin, or other substances is not as effective as laparoscopic salpingostomy.
Authors:
T Tulandi
Related Documents :
10924634 - Surgical management of interstitial pregnancy.
16468524 - Appendectomy during early pregnancy: what is the preferred surgical approach?
18304544 - Ruptured heterotopic interstitial pregnancy: rare case of acute abdomen in a jehovah's ...
18829004 - Effect of methotrexate exposure on subsequent fertility in women undergoing controlled ...
14609264 - The use of epostane in an attempt to reproduce cystic endometrial hyperplasia in the bi...
3221014 - Physical and psychological symptoms experienced by canadian women and their husbands du...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current opinion in obstetrics & gynecology     Volume:  6     ISSN:  1040-872X     ISO Abbreviation:  Curr. Opin. Obstet. Gynecol.     Publication Date:  1994 Apr 
Date Detail:
Created Date:  1994-06-30     Completed Date:  1994-06-30     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  9007264     Medline TA:  Curr Opin Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  149-52     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Female
Humans
Laparoscopy / methods*
Methotrexate / therapeutic use*
Mifepristone / therapeutic use
Pregnancy
Pregnancy Outcome
Pregnancy, Ectopic / diagnosis,  epidemiology,  therapy*
Prostaglandins / therapeutic use*
Risk Factors
Salpingostomy / methods*
Chemical
Reg. No./Substance:
0/Prostaglandins; 59-05-2/Methotrexate; 84371-65-3/Mifepristone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Advances in induction of ovulation.
Next Document:  Issues in the etiology of recurrent spontaneous abortion.